This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Suzhou Neologics Bioscience Co., Ltd.. Active years: 2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024
Title: Innovations of Jun Ma in Cancer Treatment
Introduction
Jun Ma is a notable inventor based in Nanjing, China. He has made significant contributions to the field of biotechnology, particularly in the development of therapeutic antibodies. His work focuses on innovative solutions for cancer treatment, showcasing his commitment to advancing medical science.
Latest Patents
Jun Ma holds a patent for TIM-3-targeting antibodies and their uses. This patent discloses anti-TIM-3 antibodies and antigen-binding fragments, along with polynucleotides encoding these antibodies. Additionally, it includes pharmaceutical compositions that comprise the antibodies and fragments. The patent also outlines the potential uses of these anti-TIM-3 antibodies in cancer treatment, highlighting their therapeutic applications.
Career Highlights
Jun Ma is associated with Suzhou Neologics Bioscience Co., Ltd., where he continues to innovate in the field of biotechnology. His work at the company emphasizes the importance of research and development in creating effective cancer therapies.
Collaborations
Some of his notable coworkers include Xin Dong and Jinyu Dong, who contribute to the collaborative efforts in advancing their research initiatives.
Conclusion
Jun Ma's innovative work in developing TIM-3-targeting antibodies represents a significant advancement in cancer treatment. His contributions to biotechnology are paving the way for new therapeutic options in the fight against cancer.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile